For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Spin-off companies LumetalliX and Nano Hybrids of the Van 't Hoff Institute for Molecular Sciences have been selected as finalists of the Amsterdam Science Innovation Awards 2023. where they will ‘battle’ seven other contestants. On 21 November 2023, Olivier Lugier (Nano Hybrids) and Lukas Helmbrecht (Lumetallix) will pitch their innovative ideas on stage live to the jury and audience during the festive finale at NEMO Science Museum.

An expert jury, led by Ruben Brave, and the public selected a total of nine finalists, three in each category: Society, Health, and Environment & Climate. These finalists offer innovative solutions for a wide range of societal issues. Do you want to attend the AmSIA finale live at NEMO or watch the pitches at home via live casting? 

Nano Hybrids

Nano Hybrids has developed a technology to produce hybrid core-shell nanoparticles. Sustainable by design, Nano Hybrids’ objective is to simplify and reduce the environmental impact of nanoparticle synthesis so that other innovators can be provided with these amazing materials to find solutions to big societal challenges in fields as diverse as sustainable energy, catalysis and biomedicine. Nano Hybrids was co-founded by Dr Olivier Lugier (HIMS PhD graduate) and Dr Stefania Grecea (HIMS scientific staff). More information.

LumetalliX

LumetalliX aims to provide a safe and accessible approach to lead detection. This is based on an innovative solution that effectively identifies even small traces of lead utilizing a unique reagent that makes lead light up. The technology has been extensively tested around the world and demonstrated its ease of use and reliability. LumetalliX was co-founded by Dr Lukas Helmbrecht (HIMS PhD graduate) and Prof. Wim Noorduin (HIMS scientific staff). More information.